GAO Backs ‘Universal Vaccine’ Built From Multiple Virus Fragments Fused Into One—Influenza Takes Center Stage Again

While this Frankenstein-style injection is being marketed as a tool to stop future pandemics, the virus at the center of it all is influenza—the same virus the U.S. government has spent years manipulating through gain-of-function research and now claims is on the verge of causing the next global outbreak.

“Since 2015, most clinical work on universal vaccines has focused on the flu,” the GAO states in its May 2025 Science & Tech Spotlight report.

“Multiple universal vaccine candidates targeting the flu… have reached clinical trials.”

This aligns with what we’ve already exposed: Federal agencies have been conducting bird flu gain-of-function experiments for over a decade, pushing mRNA and DNA vaccines for poultry, and stockpiling antiviral contracts—all while whispering warnings about H5N1 jumping to humans.

The Trump administration recently announced the development of a $500 million “next-generation, universal vaccine platform” called ‘Generation Gold Standard’ that will focus on avian influenza “bird flu” jab creation.

Led by Obama-nominated Comptroller General Gene Dodaro, GAO is now confirming another next step in that orchestrated rollout: a universal flu vaccine that doesn’t just target one strain—but uses recombined fragments from many strains at once.

“Scientists can now fuse together microscopic pieces of many different virus strains, increasing the number of strains that can be targeted in a single dose,” the GAO report explains.

This isn’t a new flu shot.

It’s a molecular chimera—a biotech construct made from the stitched-together parts of viruses that don’t exist naturally.

Keep reading

Unknown's avatar

Author: HP McLovincraft

Seeker of rabbit holes. Pessimist. Libertine. Contrarian. Your huckleberry. Possibly true tales of sanity-blasting horror also known as abject reality. Prepare yourself. Veteran of a thousand psychic wars. I have seen the fnords. Deplatformed on Tumblr and Twitter.

Leave a comment